Stocks to Watch Today: Tech Mahindra, HDFC Life, Bajaj Finserv, Dixon Tech in Focus on July 16
July-16, 2025: As the Indian stock market gears up for today’s trade on July 16, 2025, several key stocks are expected to draw investor attention due to earnings announcements, regulatory updates, and strategic corporate actions. Here’s a roundup of the top stocks to watch today:
These companies will announce their Q1 FY26 results today. Investors will watch closely for revenue growth, margin performance, and management commentary amid global tech volatility and domestic demand trends.
Also Read: Why Did YES Bank Shares Jump Over 3%? Will They Rise Further?
HDFC Life Insurance reported a 14.4% year-on-year rise in Q1 profit, with net earnings climbing to ₹547 crore compared to ₹478 crore in the year-ago period. The strong performance was driven by robust premium growth and improved persistency ratios.
The NBFC reported a 2% YoY decline in net profit, with Q1 PAT at ₹568 crore, down from ₹582 crore last year. Marginal compression and provisioning could be key concerns.
Dixon has signed a binding term sheet to acquire 51% stake in Kunshan Q Tech Microelectronics, bolstering its presence in precision components and expanding its manufacturing capabilities.
The pharma major secured final approval from the USFDA for its Celecoxib Capsules, used in treating pain and inflammation related to arthritis and other conditions. This could boost its U.S. generics revenue.
In a significant development, IRDAI has approved the transfer of 26% equity held by Allianz SE in both Bajaj Allianz General Insurance and Bajaj Allianz Life Insurance to Bajaj Finserv, Bajaj Holdings, and Jamnalal Sons, paving the way for increased promoter control in its insurance arms.
The local search engine company posted a 13% YoY rise in net profit for Q1, reporting ₹160 crore. The company is focusing on AI-led product enhancements and platform monetization.
The public sector lender has announced a 10 bps cut in MCLR across all loan tenures, signaling a softer interest rate regime for its borrowers.
Biocon’s biosimilar arm has received US FDA approval for KIRSTY (Insulin Aspart-xjhz), the first and only interchangeable biosimilar to NovoLog (Insulin Aspart) — a major milestone in its U.S. biologics expansion.
Phani Shankar, President and Chief Credit Officer, has resigned and will leave office on July 21. Leadership change at senior levels often raises investor focus on succession and credit strategy.
With key Q1 results, regulatory approvals, and leadership exits shaping sentiment, today’s market action is expected to be stock-specific. Traders and investors are advised to keep a close eye on the companies mentioned above.
Stocks to watch today, Tech Mahindra Q1 results, HDFC Life earnings, Dixon Technologies acquisition, Bajaj Finserv IRDAI approval, Zydus Life USFDA news, Just Dial Q1 profit, IOB MCLR cut, Biocon Insulin approval, Kotak Mahindra resignation
#StockMarketIndia #StocksToWatch #TechMahindra #HDFCLife #BajajFinserv #DixonTech #Biocon #ZydusLife #JustDial #KotakBank #IndianStockMarket #Q1Results2025 #USFDAApproval
Just over two months after the premiere of his directorial debut, the Netflix series The…
Filmmaker Ram Gopal Varma (RGV) has once again stirred controversy by defending his descriptive comments…
Nine years after her terrifying 2016 Paris robbery, Kim Kardashian made a powerful statement of…
Bollywood icon Aishwarya Rai Bachchan captivated the audience at the Red Sea Film Festival 2025…
Amid concerns over air pollution stressing the body, the choice of dairy milk can play…
India's largest airline, IndiGo, is facing an unprecedented operational crisis, with over 1,000 flights cancelled…
